| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And CEO
2 companies
Pomerantz Roger is a President And CEO at Seres Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2018 | MCRB Seres Therapeutics, Inc. | President And CEO | Sell | 1,810 | $9.00 | $16,291.27 | -0.8% | |
| Sep 6, 2018 | MCRB Seres Therapeutics, Inc. | President And CEO | Sell | 12,518 | $9.10 | $113,949.53 | -2.8% | |
| Jul 11, 2018 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 1,010 | $9.01 | $9,098.99 | -0.4% | |
| Jul 10, 2018 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 32,336 | $9.12 | $295,065.31 | -4.5% | |
| Jun 29, 2018 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 26,056 | $9.15 | $238,290.73 | -5.4% | |
| Jun 27, 2018 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 64,967 | $9.16 | $595,045.43 | -8.7% | |
| Jun 22, 2018 | MCRB Seres Therapeutics, Inc. | President And CEO | Sell | 85,536 | $9.28 | $793,906.79 | -9.5% | |
| May 9, 2018 | MCRB Seres Therapeutics, Inc. | President And CEO | Sell | 233 | $9.00 | $2,097.00 | - | |
| Jul 27, 2016 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 20,000 | $35.00 | $700,000.00 | -9.8% | |
| Jul 6, 2016 | MCRB Seres Therapeutics, Inc. | President And CEO | Sale+OE | 88,211 | $29.45 | $2,597,473.97 | -10.4% |